Persons living with diabetes are at greater risk of a number of health conditions including eye and foot problems, heart attacks and strokes, and kidney and nerve damage. A new study suggests that the earlier a woman becomes diabetic, the earlier she will likely enter menopause. Study results will be presented during The North American Menopause Society (NAMS) Annual Meeting […]
Scientists have worried since the outbreak of the Covid-19 pandemic that the virus, and the societal response to the outbreak, could have knock-on effects on health. One of the areas receiving a great deal of attention in recent months has been the potential for the pandemic to impact diabetes rates among children. The number of children with diabetes has grown […]
Researchers report that a therapeutic “step strategy,” in which patients with diabetic macular edema begin their treatment with a less expensive drug and, if vision fails to improve, switch to a more expensive medicine, produces similar results to beginning with the more expensive drug. The findings were published on July 14, 2022 in the NEJM/New England Journal of Medicine. “Our […]
Not enough men in Alberta, Canada — especially those in their 40s — are getting tested for diabetes, putting them at risk for heart disease, cancer and other complications, according to new population health research published today in The Lancet Regional Health — Americas. “My main message to young men is that early diagnosis is critical because diabetes is a huge […]
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) finds that the consumption of healthy plant-based foods, including fruits, vegetables, nuts, coffee, and legumes, is associated with a lower risk of developing type 2 diabetes (T2D) in generally healthy people and support their role in diabetes prevention. The study was conducted by Professor Frank […]
The European Commission has granted marketing authorization in the European Union (EU) for finerenone under the brand name Kerendia from Bayer HealthCare. Kerendia (10 mg or 20 mg), a non-steroidal, selective mineralocorticoid receptor antagonist, is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults. “Even when blood glucose […]
Obesity is known to cause cardiometabolic diseases like hypertension and diabetes but attributing these diseases to merely an overabundance of fat is a simplification. On a basic level, fat acts as a receptacle to store energy, but upon a closer look it is an essential actor in vital bodily processes like the immune response, the regulation of insulin sensitivity, and […]
For people with diabetes who are insulin dependent, glycemic control is a full-time job. But what if their medication could do the work for them — an insulin whose activity in the bloodstream responds to the blood glucose levels and adjusts accordingly? An invention from Indiana University School of Medicine Distinguished Professor Michael A. Weiss, MD, PhD, could lead to […]
Article by Bruce Sylvester. Patients diagnosed with type 2 diabetes and treated with weekly semaglutide have achieved an average weight loss of almost 10kg, researchers reported on March 2, 2021 in The Lancet. Put in other terms, two-thirds of subjects treated with weekly injections of a 2.4mg semaglutide lost at least 5% of their body weight and achieved significant improvement in […]
Copyright © ICR (UK) Limited t/a International Medical Information (IMI). Registered in the UK Company no. 05894351 medicalupdateonline.com is brought to you by International Medical Information. For more details, visit http://www.medicalimi.com Disclaimer: All information on this site has been collated by healthcare professionals from around the globe. Where every possible step has been taken to ensure its accuracy, MedicalUpdateOnline cannot […]
Recent Comments